Syn-Ake Peptide Nanoemulsion Shows Anti-Aging Promise

A study published in 3 Biotech reports the development of a cosmeceutical nanoemulsion formulation containing the Syn-Ake peptide, designed to address skin aging by influencing neurotransmitters. The research team evaluated the efficacy and safety of this formulation using a combination of in silico modeling and in vitro laboratory tests. The primary objective was to create a stable delivery system for the peptide that could reduce wrinkles and protect skin cells from environmental stressors such as ultraviolet radiation and oxidative damage.

The scientific rationale for this approach is based on the observation that external factors like ultraviolet radiation and oxidative stress increase reactive oxygen species in the skin, causing it to age faster. Recently, peptides have been frequently preferred in nanoformulation development to prevent these effects. The Syn-Ake peptide is specifically noted for its ability to reduce wrinkles by affecting neurotransmitters.

The study aimed to harness this property within a nanoemulsion structure to enhance its potential as an anti-aging agent. To assess the molecular interactions of the Syn-Ake peptide, the researchers employed molecular docking and molecular dynamics simulations. These computational methods were used to evaluate the anti-aging activity of the peptide.

The findings indicated that the peptide strongly interacted with the p-38 MAPK and PI3K-AKT signalling pathways. Additionally, the peptide showed significant interactions with stromelysins and gelatinases. The physical formulation of the nanoemulsion was achieved using the ultrasonic homogenization method.

The researchers produced several nanoemulsion formulations using different production procedures to determine the most stable option. Stability and characterization studies were conducted on these formulations. The study determined the most stable formulation among those developed with the various production procedures.

Safety evaluations were conducted to ensure the formulation would not cause harm to cells. Genotoxicity and cytotoxicity studies were performed to evaluate the in vitro safety of the formulation. The results showed that the nanoemulsion formulation was non-genotoxic and cytocompatible.

The cell regenerative effect of the formulation was evaluated using a scratch test. The study found that the formulation possessed cell regenerative properties. To test the protective capabilities of the formulation, researchers evaluated its effect against H2O2-UV-induced skin damage.

The study assessed the protective effect of the nanoemulsion at both the cellular and DNA levels. The results demonstrated that the formulation was protective against this specific type of damage. In addition to its protective effects, the formulation was assessed for its antioxidant and collagenase inhibitory activities.

The results confirmed that the nanoemulsion showed antioxidant activity. The findings of this study suggest that the Syn-Ake peptide nanoemulsion has promising potential as an anti-aging product candidate. The study concludes that the formulation of Syn-Ake peptide in nanoemulsion was evaluated to have promising potential as an anti-aging product candidate with a high efficacy and safety profile.

Subject of Research: Development and evaluation of a Syn-Ake peptide nanoemulsion for anti-aging cosmeceutical applications

Article Title: Development of cosmeceutical nanoemulsion formulation containing peptide acting on neurotransmitters and evaluation of its efficacy

Article References: Gok, B., Budama-Kilinc, Y., & Kecel-Gunduz, S. (2026). Development of cosmeceutical nanoemulsion formulation containing peptide acting on neurotransmitters and evaluation of its efficacy. 3 Biotech, 16(11), Article 477. https://doi.org/10.1007/s13205-026-05090-6

Image Credits: AI Generated

DOI: 10.1007/s13205-026-05090-6

Keywords: nanoemulsion, Syn-Ake peptide, anti-aging, cosmeceutical, molecular docking, skin care, oxidative stress, UV protection, collagenase inhibition, in vitro studies, Development, formulation